Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1091-1100 of 11769

Edit search filters
  1. Blood Volume and Hemodynamic Analysis in Patients With Chronic Heart Failure

    Rochester, MN

  2. ALLIANCE AVIV: Safety And Effectiveness Of The SAPIEN X4 Transcatheter Heart Valve In Failing Aortic Bioprosthetic Valves

    Rochester, MN

  3. A Study Of Flyte System Transvaginal Mechanotherapy For Endometrial And Cervical Cancer

    Rochester, MN

  4. Radiation Therapy With Or Without Temozolomide In Treating Patients With Low-Grade Glioma

    Jacksonville, FL, Rochester, MN

  5. A Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Anti-tumor Activity Of WSD0922-FU

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. A Molecular Anatomic Imaging Analysis Of Tau In Progressive Supranuclear Palsy

    Rochester, MN

  7. [Trial Of Device That Is Not Approved Or Cleared By The U.S. FDA]

    Rochester, MN

  8. Clinical Study Protocol For Cutaneous SCC For Immunocompromised Patients

    Rochester, MN

  9. Study Of NXP900 With Osimertinib In Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. A Study Of MACI In Patients Aged 17 To 65 Years With Symptomatic Chondral Or Osteochondral Defects Of The Ankle

    Rochester, MN

.

Mayo Clinic Footer